Development and characterisation of an in vitro human gut model to study the biofilm mode of growth of Clostridium difficile and the indigenous gut microbiota
Clostridium difficile infection (CDI) is associated with significant patient morbidity, mortality and financial burden. Until recently, antimicrobial treatment options were limited to metronidazole and vancomycin, but both agents are associated with recurrence rates of approximately 20%. The human g...
Main Author: | Crowther, Grace |
---|---|
Other Authors: | Wilcox, Mark |
Published: |
University of Leeds
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.605228 |
Similar Items
-
Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.
by: Grace S Crowther, et al.
Published: (2014-01-01) -
Colonization Resistance of the Gut Microbiota against Clostridium difficile
by: Ana Elena Pérez-Cobas, et al.
Published: (2015-08-01) -
Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
by: Caroline Vincent, et al.
Published: (2015-07-01) -
Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes.
by: Jure Skraban, et al.
Published: (2013-01-01) -
Structural and functional changes in the gut microbiota associated to Clostridium difficile infection
by: Ana Elena Pérez-Cobas, et al.
Published: (2014-07-01)